Crinetics Pharmaceuticals Inc (CRNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 101,536 | 110,901 | 53,726 | 94,569 | 264,545 |
| Marketable Securities | 926,353 | 981,890 | 1,143,134 | 1,180,055 | 1,090,024 |
| Receivables | 592 | N/A | N/A | N/A | N/A |
| Inventories | 2,022 | N/A | N/A | N/A | N/A |
| TOTAL | $1,048,342 | $1,121,275 | $1,217,264 | $1,291,055 | $1,375,388 |
| Non-Current Assets | |||||
| PPE Net | 14,296 | 14,377 | 14,670 | 12,628 | 12,068 |
| Other Non-Current Assets | 63,619 | 60,379 | 57,640 | 57,644 | 47,136 |
| TOTAL | $77,915 | $74,756 | $72,310 | $70,272 | $59,204 |
| Total Assets | $1,126,257 | $1,196,031 | $1,289,574 | $1,361,327 | $1,434,592 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 41,770 | 33,674 | 38,086 | 31,616 | 21,469 |
| Accrued Expenses | 35,578 | 32,398 | 21,796 | 16,606 | 28,887 |
| TOTAL | $85,072 | $74,155 | $68,396 | $57,311 | $59,684 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 1,235 | 1,642 | 1,904 | 2,206 | 2,176 |
| Other Non-Current Liabilities | 45,292 | 45,597 | 45,660 | 45,703 | 45,399 |
| TOTAL | $49,102 | $49,707 | $49,652 | $50,016 | $50,103 |
| Total Liabilities | $134,174 | $123,862 | $118,048 | $107,327 | $109,787 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 104,705 | 94,892 | 94,176 | 93,680 | 93,049 |
| Common Shares | 2,407,757 | 2,364,699 | 2,334,538 | 2,300,882 | 2,275,952 |
| Retained earnings | -1,417,427 | -1,294,612 | -1,164,521 | -1,048,884 | -952,110 |
| Other shareholders' equity | 1,753 | 2,082 | 1,509 | 2,002 | 963 |
| TOTAL | $992,083 | $1,072,169 | $1,171,526 | $1,254,000 | $1,324,805 |
| Total Liabilities And Equity | $1,126,257 | $1,196,031 | $1,289,574 | $1,361,327 | $1,434,592 |